medical management The following should be provided to all inpatients and outpatients with SAM: Antibiotic From D1, unless specific signs of infection are present: treatment amoxicillin PO: 50 mg/kg (max. 1 g) 2 times daily for 5 to 7 days Malaria On D1, rapid diagnostic test in endemic areas and treatment for malaria according to results or if testing is not available (see Malaria, Chapter 6). Intestinal In transition phase or upon outpatient admission, albendazole PO: parasites Children 12 to 23 months: 200 mg single dose Children 24 months and over: 400 mg single dose Vaccination In transition phase or upon outpatient admission, measles vaccine for children 6 months to 5 years, unless a document shows that the child received 2 doses of vaccine administered as follows: one dose at or after 9 months and one dose at least 4 weeks after the first dose. Children vaccinated between 6 and 8 months should be re-vaccinated as above (i.e. with 2 doses) once they reach 9 months of age, provided that an interval of 4 weeks from the first dose is respected. Other vaccines included in the EPI: check vaccination status and refer the child to vaccination services at discharge. Tuberculosis At D1 then regularly during treatment, screen for TB. For a child screening positive, perform (TB) complete diagnostic evaluation. For more information, refer to the guide Tuberculosis, MSF. HIV infection Perform HIV counselling and testing (unless the mother explicitly declines testing). Children under 18 months: test the mother with rapid diagnostic tests. For a mother testing positive, request PCR test for the child. Children 18 months and over: test the child with rapid diagnostic tests. Page 56 / 409